Apex Pharm Ltd

POWER SEARCH PRICING

SOLUTIONS

apex pharm ltd Company Information

Company Number

08304463

Next Accounts

Sep 2025

Directors

Amir Ikhlas

Mohammed Shahzad

View All

Shareholders

tahir mahmood

amir waheed ikhlas

View All

Group Structure

View All

Industry

Other human health activities

Registered Address

suite 1, 177 lees road, oldham, OL4 1JP

Website

www.apexpharmacy.co.uk

apex pharm ltd Estimated Valuation

£1.8m

Pomanda estimates the enterprise value of APEX PHARM LTD at £1.8m based on a Turnover of £4.1m and 0.43x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Apex Pharm Ltd is a live company located in oldham, OL4 1JP with a Companies House number of 08304463. It operates in the other human health activities sector, SIC Code 86900. Founded in November 2012, it's largest shareholder is tahir mahmood with a 33.3% stake. Apex Pharm Ltd is a established, small sized company, Pomanda has estimated its turnover at £4.1m with healthy growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Apex Pharm Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs

Health Rating3.5out of 5

5 Strong

1 Regular

4 Weak

Size

annual sales of £4.1m, make it larger than the average company (£797.3k)

Growth

3 year (CAGR) sales growth of 13%, show it is growing at a faster rate (6.5%)

EXPORT

Apex Pharm Ltd's latest turnover from December 2023 is estimated at £4.1 million and the company has net assets of £269.6 thousand. According to their latest financial statements, Apex Pharm Ltd has 27 employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013
Turnover	4,108,381	3,269,275	3,406,179	2,847,342	2,068,642	898,445	2,692,338	2,576,901	1,152,397	401,728	475,382
Other Income Or Grants
Cost Of Sales	3,244,049	2,606,713	2,762,733	2,303,304	1,651,714	725,922	2,118,760	2,012,840	927,188	325,921	386,673
Gross Profit	864,332	662,563	643,446	544,039	416,928	172,523	573,578	564,062	225,209	75,807	88,709
Admin Expenses	759,605	630,291	630,758	550,999	387,493	153,169	525,800	530,948	176,917	62,033	81,473
Operating Profit	104,727	32,272	12,688	-6,960	29,435	19,354	47,778	33,114	48,292	13,774	7,236
Interest Payable
Interest Receivable								368	1,148	577	164
Pre-Tax Profit	104,727	32,272	12,688	-6,960	29,435	19,354	47,778	33,483	49,440	14,351	7,400
Tax	-26,182	-6,132	-2,411		-5,593	-3,677	-9,078	-6,696	-9,888	-3,014	-1,702
Profit After Tax	78,545	26,140	10,277	-6,960	23,842	15,677	38,700	26,786	39,552	11,337	5,698
Dividends Paid
Retained Profit	78,545	26,140	10,277	-6,960	23,842	15,677	38,700	26,786	39,552	11,337	5,698
Employee Costs	727,707	638,273	244,048	236,250	233,194	272,675	704,000	637,381	293,409	129,297	148,833
Number Of Employees	27	25	10	10	10	12	32	30	14	6	7
EBITDA*	104,727	32,272	12,688	-6,960	29,435	19,354	47,778	33,114	50,824	15,736	8,988

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013
Tangible Assets	441,648	364,184	373,143	385,098	368,693	319,939	17,019	8,665	10,128	10,915	8,792
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets	441,648	364,184	373,143	385,098	368,693	319,939	17,019	8,665	10,128	10,915	8,792
Stock & work in progress									43,000	41,860	33,260
Trade Debtors	1,084,337	883,270	947,164	729,226	500,478	160,411	435,549	408,778		647
Group Debtors
Misc Debtors
Cash									294,504	164,839	65,764
misc current assets
total current assets	1,084,337	883,270	947,164	729,226	500,478	160,411	435,549	408,778	337,504	207,346	99,024
total assets	1,525,985	1,247,454	1,320,307	1,114,324	869,171	480,350	452,568	417,443	347,632	218,261	107,816
Bank overdraft
Bank loan
Trade Creditors	1,233,161	1,022,414	1,110,983	909,692	707,579	342,600	330,495	334,070	290,945	201,126	102,018
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities	1,233,161	1,022,414	1,110,983	909,692	707,579	342,600	330,495	334,070	290,945	201,126	102,018
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities	23,230	33,991	44,415	50,000
provisions
total long term liabilities	23,230	33,991	44,415	50,000
total liabilities	1,256,391	1,056,405	1,155,398	959,692	707,579	342,600	330,495	334,070	290,945	201,126	102,018
net assets	269,594	191,049	164,909	154,632	161,592	137,750	122,073	83,373	56,687	17,135	5,798
total shareholders funds	269,594	191,049	164,909	154,632	161,592	137,750	122,073	83,373	56,687	17,135	5,798

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013
Operating Activities
Operating Profit	104,727	32,272	12,688	-6,960	29,435	19,354	47,778	33,114	48,292	13,774	7,236
Depreciation									2,532	1,962	1,752
Amortisation
Tax	-26,182	-6,132	-2,411		-5,593	-3,677	-9,078	-6,696	-9,888	-3,014	-1,702
Stock								-43,000	1,140	8,600	33,260
Debtors	201,067	-63,894	217,938	228,748	340,067	-275,138	26,771	408,778	-647	647
Creditors	210,747	-88,569	201,291	202,113	364,979	12,105	-3,575	43,125	89,819	99,108	102,018
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations	88,225	1,465	-6,370	-33,595	48,754	302,920	8,354	-296,235	130,262	102,583	76,044
Investing Activities
capital expenditure	-77,464	8,959	11,955	-16,405	-48,754	-302,920	-8,354	1,463	-1,745	-4,085	-10,544
Change in Investments
cash flow from investments	-77,464	8,959	11,955	-16,405	-48,754	-302,920	-8,354	1,463	-1,745	-4,085	-10,544
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities	-10,761	-10,424	-5,585	50,000
share issue								-100			100
interest								368	1,148	577	164
cash flow from financing	-10,761	-10,424	-5,585	50,000				268	1,148	577	264
cash and cash equivalents
cash								-294,504	129,665	99,075	65,764
overdraft
change in cash								-294,504	129,665	99,075	65,764

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for apex pharm ltd. Get real-time insights into apex pharm ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for apex pharm ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in OL4 area or any other competitors across 12 key performance metrics.

APEX PHARM LTD group structure

Apex Pharm Ltd has no subsidiary companies.

Ultimate parent company

APEX PHARM LTD

08304463

APEX PHARM LTD Shareholders

tahir mahmood	33.33%
amir waheed ikhlas	33.33%
mohammed khuram shahzad	33.33%

Apex Pharm Ltd currently has 3 directors. The longest serving directors include Mr Amir Ikhlas (Nov 2012) and Mr Mohammed Shahzad (Nov 2012).

officer	country	age	start	end	role
Mr Amir Ikhlas	United Kingdom	39 years	Nov 2012	-	Director
Mr Mohammed Shahzad	England	42 years	Nov 2012	-	Director
Mr Tahir Mahmood	England	44 years	Jan 2018	-	Director

P&L

December 2023

turnover

4.1m

+26%

operating profit

104.7k

gross margin

21.1%

+3.81%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

269.6k

+0.41%

total assets

1.5m

+0.22%

cash

net assets

Total assets minus all liabilities

Similar Companies

the gastric balloon centre limited

1.5

fishawack facilitate limited

sites ambulance service limited

2.5

concept medicine ltd

2.5

hearing matters ltd

1.5

company number

08304463

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

November 2012

ultimate parent company

None

previous names

N/A

address

suite 1, 177 lees road, oldham, OL4 1JP

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to apex pharm ltd.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for APEX PHARM LTD. This can take several minutes, an email will notify you when this has completed.

apex pharm ltd Company Information

apex pharm ltd Estimated Valuation

apex pharm ltd Estimated Valuation

apex pharm ltd Estimated Valuation

Apex Pharm Ltd Overview

Apex Pharm Ltd Health Check

APEX PHARM LTD financials

apex pharm ltd Credit Report and Business Information

Apex Pharm Ltd Competitor Analysis

apex pharm ltd Ownership

apex pharm ltd directors

apex pharm ltd company details

apex pharm ltd Charges & Mortgages

apex pharm ltd Capital Raised & Share Issues BETA

apex pharm ltd Companies House Filings - See Documents